Genetic Variant of IRAK2 in the Toll-Like Receptor Signaling Pathway and Survival of Non-Small Cell Lung Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.31660
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Genetic Polymorphisms in the Vitamin D Pathway and Non-Small Cell Lung Cancer Survival

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2019English

Hypoxia Exacerbates Inflammatory Acute Lung Injury via the Toll-Like Receptor 4 Signaling Pathway

Frontiers in Immunology
AllergyImmunology
2018English

Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated With Survival in Late-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2011English

OA01 LKB1 Pathway Variant TSC2 Rs30259 Predicts the Prognosis in Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Genetic Variations in miR-125 Family and the Survival of Non-Small Cell Lung Cancer in Chinese Population

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Curcumin Induces the Apoptosis of Non-Small Cell Lung Cancer Cells Through a Calcium Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2015English

FAM98A Promotes Proliferation of Non-Small Cell Lung Cancer Cells via the P38-Atf2 Signaling Pathway

Cancer Management and Research
Oncology
2018English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

Activation of Insulin-Like Growth Factor 1 Receptor in Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy